XiaoLing Zhang – Trademark Portfolio
Entity Type: 01
XiaoLing Zhang owns a portfolio of 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as MAYSTORY, AEOLUMANI, and VIVIDHAVEN. Of these, 3 are registered and 2 are pending. The portfolio spans 5 Nice Classification classes, led by Class 9 (Computers & Electronics) and Class 26 (Fancy Goods). Headquartered in Xi'an City,ShanXi.
Jiuzuohuayuan Business center 1808 room
Nanerhuan Xiduan Road. Lianhu district
Xi'an City,ShanXi 710000 , CN
Showing of trademarks Trademarks
Trademark Classifications
XiaoLing Zhang's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Lace and embroidery, ribbons and braid; buttons, hooks and eyes, pins and needles
Leather and imitations of leather; animal skins, hides; trunks and travelling bags
Frequently Asked Questions
How many trademarks does XiaoLing Zhang have?
XiaoLing Zhang has 5 U.S. trademarks filed with the USPTO. Of these, 3 registered, 2 pending.
What trademark classes does XiaoLing Zhang file in?
XiaoLing Zhang files trademarks across 5 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 26 (Fancy Goods), Class 21 (Housewares), Class 18 (Leather Goods), Class 7 (Machinery). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are XiaoLing Zhang's most well-known trademarks?
XiaoLing Zhang's registered trademark portfolio includes well-known marks such as MAYSTORY, AEOLUMANI, and VIVIDHAVEN. These are among 3 currently registered trademarks in the portfolio.
What is XiaoLing Zhang's trademark registration success rate?
XiaoLing Zhang has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 2 applications are pending review.